Видео с ютуба Functionally High-Risk Disease

The impact of functionally high-risk disease in patients with R/R myeloma receiving late-line CAR-T

Cilta-cel versus SoC in functionally high-risk myeloma with one prior therapy

FAQs on High-Risk Disease

What does it mean to have functional high-risk multiple myeloma?

The Key Traits of High-Risk and Functional High-Risk Multiple Myeloma Explained

Identifying and treating high-risk patients in 2023

High-Risk Disease | High Impact Topic (HIT)

What is HRMM (High-Risk Multiple Myeloma)? #myeloma

High-Risk vs. Standard-Risk Multiple Myeloma: What Patients Need to Know in 1 Minute

HIGH RISK MYELOMA MANAGEMENT

Myeloma: tackling high-risk disease

High-risk myeloma: How and should it be treated differently

Real-world treatment patterns & outcomes of functional high-risk myeloma

Debating high-risk disease biology at COMy 2021

High-risk disease biology in multiple myeloma

All that you must know about high-risk myeloma: from diagnosis to treatment.

The impact of induction therapy on outcomes for patients with functional high-risk myeloma

Managing patients with difficult to treat multiple myeloma

What is High-Risk Disease? - Sarah Holstein, MD | MCRT Webcast November 21 (6/10)

Defining High-Risk Disease in Multiple Myeloma